Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor

NCT05616650 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

42

Enrollment

NIH

Sponsor class

Conditions

Prostatic Neoplasms
Prostate Cancer
Prostate Adenocarcinoma

Interventions

DRUG: 18F-DCFPyL
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

National Cancer Institute (NCI)